Gerhard Mayr - UCB SA Insider

UCB SA -- USA Stock  

USD 42.47  1.18  2.86%

Non-Executive Chairman of the Board

Mr. Gerhard N. Mayr has served as NonExecutive Chairman of the Board of U C B S.A. since May 2012. He served as NonExecutive Independent Director of the Company between June 14, 2005 and May 2012. He received a Master degree in Chemical Engineering from the Swiss Federal Institute of Technology in 1969, and a MBA degree from Stanford University in 1972. In March 2004, he retired as Executive Vice President of pharmaceutical operations at Eli Lilly Company after 32 years of service
Age: 68  Chairman Since 2012      
32 2 559 99 99
Mayr is Member of the Board of Lonza Group Ltd ., Member of the Board of the Vienna Science, Research and Technology Foundation and Member of the Board of Project Hope, United States . He is Member of the circle of patrons of INSEAD Business School . He was previously Member of the board of Alcon, Inc

Management Efficiency

The company has return on total asset (ROA) of 5.76 % which means that it generated profit of $5.76 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.02 % meaning that it generated $13.02 on every $100 dollars invested by stockholders.
The company has accumulated 1.92 B in total debt with debt to equity ratio (D/E) of 28.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UCB SA has Current Ratio of 1.09 suggesting that it may not have the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records


Michael TreschowUnilever N V
Marijn DekkersUnilever N V

Entity Summary

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. UCB SA (UCBJY) is traded on OTC Market in USA. It is located in Allée de la Recherche, Brussels, and employs 7,643 people.

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance
Hide  View All  NextLaunch Transaction History
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add UCB SA to your portfolio

Top Management

UCB SA Leadership Team
Pascale Richetta, President
Detlef Thielgen, CFO
Kay Davies, Director
Anna Richo, EVP
Gerhard Mayr, Chairman
Cyril Janssen, Director
Cedric Rijckevorsel, Director, CFA
JeanChristophe Tellier, Chairman
Arnoud Calesberg, Director
Mark McDade, COO
Xavier Michel, President
Bharat Tewarie, President, MBA
Roch Doliveux, Chairman, Ph.D
Norman Ornstein, Director
Jeff Wren, President
JeanPierre Kinet, Director, Ph.D
Antje Witte, VP
Alice Dautry, Director
Harriet Edelman, Director, MBA
Ulf Wiinberg, Director
Thomas McKillop, Director, Ph.D
Charl Zyl, President
Fabrice Enderlin, President
Pierre Gurdjian, Director
Ismail Kola, EVP, Ph.D
Emmanuel Caeymaex, President
Evelyn Bergendal, Executive
Iris LoewFriedrich, President, Ph.D
CharlesAntoine Janssen, Director
Albrecht Graeve, Director

Stock Performance

UCB SA Performance Indicators